Centessa Pharmaceuticals CEO Saha sells shares worth $867,430
Following these transactions, Saha holds 429,398 shares directly. Additionally, he maintains indirect ownership of 38,000 ...
Stocks to Watch Today: HUL, BPCL, Laurus Labs, Stallion India, Persistent Systems, Pidilite, Cigniti Technologies in focus on 23 January
Stocks like Bharat Petroleum Corporation,Gravita India, Laxmi Organic Industries, Go Digit General Insurance, Laurus Labs, ...
Raj Television
Find Raj Television Network Ltd. Technical Chart BSE Analysis on The Economic Times. Get Raj Television Network Ltd. Technical Charts Real-time and intraday charts, Raj Television Network Ltd. Stock ...
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
Aakash Exploration
Find Aakash Exploration Services Ltd. Technical Chart NSE Analysis on The Economic Times. Get Aakash Exploration Services Ltd. Technical Charts Real-time and intraday charts, Aakash Exploration ...
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Business Insider6d
Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia
Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX ... has exercised 221,161 warrants outstanding with Santhera at an exercise price of CHF 9.043 per share and an expiry date of ...